PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Acharya, R.* ; Mahapatra, A.* ; Verma, H.K. ; Bhaskar, L.V.K.S.*

Unveiling therapeutic targets for esophageal cancer: A comprehensive review.

Curr. Oncol. 30, 9542-9568 (2023)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Esophageal cancer is a highly aggressive and deadly disease, ranking as the sixth leading cause of cancer-related deaths worldwide. Despite advances in treatment, the prognosis remains poor. A multidisciplinary approach is crucial for achieving complete remission, with treatment options varying based on disease stage. Surgical intervention and endoscopic treatment are used for localized cancer, while systemic treatments like chemoradiotherapy and targeted drug therapy play a crucial role. Molecular markers such as HER2 and EGFR can be targeted with drugs like trastuzumab and cetuximab, and immunotherapy drugs like pembrolizumab and nivolumab show promise by targeting immune checkpoint proteins. Epigenetic modifications offer new avenues for targeted therapy. Treatment selection depends on factors like stage, tumor location, and patient health, with post-operative and rehabilitation care being essential. Early diagnosis, appropriate treatment, and supportive care are key to improving outcomes. Continued research is needed to develop effective targeted drugs with minimal side effects. This review serves as a valuable resource for clinicians and researchers dedicated to enhancing esophageal cancer treatment outcomes.
Impact Factor
Scopus SNIP
Altmetric
2.600
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Esophageal Cancer ; Molecular Markers ; Multidisciplinary Approach ; Prognosis ; Targeted Therapy; Quality-of-life; Endoscopic Submucosal Dissection; Minimally Invasive Mckeown; Endothelial Growth-factor; Squamous-cell Carcinoma; Term-follow-up; Mucosal Resection; Esophagogastric Junction; Barretts-esophagus; Management
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 1198-0052
e-ISSN 1718-7729
Zeitschrift Current Oncology
Quellenangaben Band: 30, Heft: 11, Seiten: 9542-9568 Artikelnummer: , Supplement: ,
Verlag MDPI
Verlagsort St Alban-anlage 66, Ch-4052 Basel, Switzerland
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)
POF Topic(s) 80000 - German Center for Lung Research
Forschungsfeld(er) Lung Research
PSP-Element(e) G-501810-007
DOI 10.3390/curroncol30110691
WOS ID 001119955200001
PubMed ID 37999111
Erfassungsdatum 2023-12-19
[➜Korrektur melden]